Skip to main content
Erschienen in: International Journal of Hematology 2/2018

26.09.2017 | Original Article

Persistent changes in circulating white blood cell populations after splenectomy

verfasst von: Minke A. E. Rab, Aafke Meerveld-Eggink, Heleen van Velzen-Blad, Douwe van Loon, Ger T. Rijkers, Okke de Weerdt

Erschienen in: International Journal of Hematology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

The effect of splenectomy on the incidence of infections and thromboembolisms has been investigated thoroughly. Nevertheless, the long-term effects of splenectomy on immunological profile and circulating blood counts have not been described before. To study such long-term effects, we analysed several parameters in splenectomised trauma patients and compared the results of this group (“otherwise healthy patients”) to patients with a specific underlying disease. We measured platelet count, leukocytes and differential, lymphocyte subsets, serum levels of immunoglobulins, and complement pathways in 113 patients. Indications to perform a splenectomy were trauma (n = 42), Hodgkin lymphoma (n = 24), hereditary spherocytosis (n = 21), and immune thrombocytopenia (n = 26). In trauma patients lymphocytes and lymphocytes subsets were particularly elevated compared to normal population values. Splenectomised patients with Hodgkin lymphoma had significant lower numbers of T lymphocytes than trauma patients. Significant increases in platelets, leukocytes, and monocytes were observed in patients with hereditary spherocytosis. Occurrence of MBL genotype was different in ITP patients than in other splenectomised groups and the normal population. In splenectomised patients (> 4 years), platelet counts and lymphocyte subsets are increased which persist over time. As a result, these blood counts in splenectomised patients differ from reference values in the normal population.
Literatur
1.
Zurück zum Zitat Davies JM, Lewis MPN, Wimperis J, Rafi I, Ladhani S, Bolton-Maggs PHB. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a Working Party of the Haemato-Oncology Task Force. Br J Haematol. 2011;155:308–17.CrossRefPubMed Davies JM, Lewis MPN, Wimperis J, Rafi I, Ladhani S, Bolton-Maggs PHB. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a Working Party of the Haemato-Oncology Task Force. Br J Haematol. 2011;155:308–17.CrossRefPubMed
2.
Zurück zum Zitat Toutouzas KG, Velmahos GC, Kaminski A, Chan L, Demetriades D. Leukocytosis after posttraumatic splenectomy. Arch Surg. 2002;137:924–8.CrossRefPubMed Toutouzas KG, Velmahos GC, Kaminski A, Chan L, Demetriades D. Leukocytosis after posttraumatic splenectomy. Arch Surg. 2002;137:924–8.CrossRefPubMed
3.
Zurück zum Zitat Weng J, Brown CVR, Rhee P, Salim A, Chan L, Demetriades D, et al. White blood cell and platelet counts can be used to differentiate between infection and the normal response after splenectomy for trauma: prospective validation. J Trauma Inj Infect Crit Care. 2005;117:1076–80.CrossRef Weng J, Brown CVR, Rhee P, Salim A, Chan L, Demetriades D, et al. White blood cell and platelet counts can be used to differentiate between infection and the normal response after splenectomy for trauma: prospective validation. J Trauma Inj Infect Crit Care. 2005;117:1076–80.CrossRef
4.
Zurück zum Zitat Banerjee A, Kelly KB, Zhou HY, Dixon SD, Papana Dagiasis A, Quinn LM, et al. Diagnosis of Infection after splenectomy for trauma should be based on lack of platelets rather than white blood cell count. Surg Infect. 2014;15:221–6.CrossRef Banerjee A, Kelly KB, Zhou HY, Dixon SD, Papana Dagiasis A, Quinn LM, et al. Diagnosis of Infection after splenectomy for trauma should be based on lack of platelets rather than white blood cell count. Surg Infect. 2014;15:221–6.CrossRef
5.
Zurück zum Zitat Cameron PU, Jones P, Gorniak M, Dunster K, Paul E, Lewin S, et al. Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort. PLoS One. 2011;6:e23164.CrossRefPubMedPubMedCentral Cameron PU, Jones P, Gorniak M, Dunster K, Paul E, Lewin S, et al. Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort. PLoS One. 2011;6:e23164.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Meerveld-Eggink A, de Weerdt O, de Voer RM, Berbers GAM, van Velzen-Blad H, Vlaminckx BJ, et al. Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients. Eur J Clin Microbiol Infect Dis. 2011;30:611–8.CrossRefPubMed Meerveld-Eggink A, de Weerdt O, de Voer RM, Berbers GAM, van Velzen-Blad H, Vlaminckx BJ, et al. Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients. Eur J Clin Microbiol Infect Dis. 2011;30:611–8.CrossRefPubMed
7.
Zurück zum Zitat Meerveld-Eggink A, de Weerdt O, van Velzen-Blad H, Biesma DH, Rijkers GT. Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients. Vaccine. 2011;29:675–80.CrossRefPubMed Meerveld-Eggink A, de Weerdt O, van Velzen-Blad H, Biesma DH, Rijkers GT. Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients. Vaccine. 2011;29:675–80.CrossRefPubMed
8.
Zurück zum Zitat Meerveld-Eggink A, de Weerdt O, Rijkers GT, van Velzen-Blad H, Biesma DH. Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands. Vaccine. 2008;26:6975–9.CrossRefPubMed Meerveld-Eggink A, de Weerdt O, Rijkers GT, van Velzen-Blad H, Biesma DH. Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands. Vaccine. 2008;26:6975–9.CrossRefPubMed
9.
Zurück zum Zitat Comans-Bitter WM, De Groot R, Van den Beemd R, Neijens HJ, Hop WCJ, Groeneveld K, et al. Immunophenotyping of blood lymphocytes in childhood: reference values for lymphocyte subpopulations. J Pediatr. 1997;130:388–93.CrossRefPubMed Comans-Bitter WM, De Groot R, Van den Beemd R, Neijens HJ, Hop WCJ, Groeneveld K, et al. Immunophenotyping of blood lymphocytes in childhood: reference values for lymphocyte subpopulations. J Pediatr. 1997;130:388–93.CrossRefPubMed
10.
Zurück zum Zitat Vlug A, Nieuwenhuys E, van Eijk R, Geertzen H, van Houte A. Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin. 1994;52(7–8):561–7. Vlug A, Nieuwenhuys E, van Eijk R, Geertzen H, van Houte A. Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin. 1994;52(7–8):561–7.
11.
Zurück zum Zitat Seelen MW, Roos A, Wieslander J, Mollnes TE, Sjöholm G, Wurzner R, et al. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods. 2005;296:187–98.CrossRefPubMed Seelen MW, Roos A, Wieslander J, Mollnes TE, Sjöholm G, Wurzner R, et al. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods. 2005;296:187–98.CrossRefPubMed
12.
Zurück zum Zitat Endeman H, Herpers BL, De Jong BW, Voorn GP, Grutters JC, Van Velzen-Blad H, et al. Mannose-binding lectin genotypes in susceptibility to community-acquired pneumonia. Chest. 2008;134:1135–40.CrossRefPubMed Endeman H, Herpers BL, De Jong BW, Voorn GP, Grutters JC, Van Velzen-Blad H, et al. Mannose-binding lectin genotypes in susceptibility to community-acquired pneumonia. Chest. 2008;134:1135–40.CrossRefPubMed
13.
Zurück zum Zitat Schoonen MW, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, et al. Epidemiology of immune thrombocytopenic purpura in the general practice research database. Br J Haematol. 2009;145:235–44.CrossRefPubMed Schoonen MW, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, et al. Epidemiology of immune thrombocytopenic purpura in the general practice research database. Br J Haematol. 2009;145:235–44.CrossRefPubMed
14.
Zurück zum Zitat Blum KS, Pabst R. Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs? Immunol Lett. 2007;108:45–51.CrossRefPubMed Blum KS, Pabst R. Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs? Immunol Lett. 2007;108:45–51.CrossRefPubMed
15.
Zurück zum Zitat Bessler H, Bergman M, Salman H, Beilin B, Djaldetti M. The relationship between partial splenectomy and peripheral leukocyte count. J Surg Res. 2004;122:49–53.CrossRefPubMed Bessler H, Bergman M, Salman H, Beilin B, Djaldetti M. The relationship between partial splenectomy and peripheral leukocyte count. J Surg Res. 2004;122:49–53.CrossRefPubMed
16.
Zurück zum Zitat Miko I, Nemeth N, Sajtos E, Brath E, Peto K, Furka A, et al. Splenic function and red blood cell deformability: the beneficial effects of spleen autotransplantation in animal experiments. Clin Hemorheol Microcirc. 2010;45:281–8.PubMed Miko I, Nemeth N, Sajtos E, Brath E, Peto K, Furka A, et al. Splenic function and red blood cell deformability: the beneficial effects of spleen autotransplantation in animal experiments. Clin Hemorheol Microcirc. 2010;45:281–8.PubMed
17.
Zurück zum Zitat Sipka S, Bráth E, Tóth FF, Aleksza M, Kulcsár A, Fábián A, et al. Cellular and serological changes in the peripheral blood of splenectomized and spleen autotransplanted mice. Transpl Immunol. 2006;16:99–104.CrossRefPubMed Sipka S, Bráth E, Tóth FF, Aleksza M, Kulcsár A, Fábián A, et al. Cellular and serological changes in the peripheral blood of splenectomized and spleen autotransplanted mice. Transpl Immunol. 2006;16:99–104.CrossRefPubMed
18.
Zurück zum Zitat Seabrook TJ, Hein WR, Dudler L, Young AJ. Splenectomy selectively affects the distribution and mobility of the recirculating lymphocyte pool. Blood. 2000;96:1180–3.PubMed Seabrook TJ, Hein WR, Dudler L, Young AJ. Splenectomy selectively affects the distribution and mobility of the recirculating lymphocyte pool. Blood. 2000;96:1180–3.PubMed
19.
Zurück zum Zitat Chaimoff C, Douer D, Pick IA, Pinkhas J. Serum lmmunoglobulin changes after accidental splenectomy in adults. Am J Surg Surg. 1978;136:332–3.CrossRef Chaimoff C, Douer D, Pick IA, Pinkhas J. Serum lmmunoglobulin changes after accidental splenectomy in adults. Am J Surg Surg. 1978;136:332–3.CrossRef
20.
Zurück zum Zitat Order SE. The effects of therapeutic irradiation on lymphocytes and immunity. Cancer. 1977;39:737–43.CrossRefPubMed Order SE. The effects of therapeutic irradiation on lymphocytes and immunity. Cancer. 1977;39:737–43.CrossRefPubMed
21.
Zurück zum Zitat Bjorkholm M, Holm G, Hospital S. Persisting lymphocyte deficiences during remission in Hodgkin’ s disease. Clin Exp Immunol. 1977;28:389–93.PubMedPubMedCentral Bjorkholm M, Holm G, Hospital S. Persisting lymphocyte deficiences during remission in Hodgkin’ s disease. Clin Exp Immunol. 1977;28:389–93.PubMedPubMedCentral
22.
Zurück zum Zitat Fuks Z, Strober S, Bobrove AM, Sasazuki T, McMichael A, Kaplan HS. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin’s disease. J Clin Invest. 1976;58:803–14.CrossRefPubMedPubMedCentral Fuks Z, Strober S, Bobrove AM, Sasazuki T, McMichael A, Kaplan HS. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin’s disease. J Clin Invest. 1976;58:803–14.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Bjorkholm M, Askergren J, Holm G, Mellstedt H. Long-term influence of splenectomy on immune functions in patients with Hodgkins disease. Scand J Haematol. 1980;24:87–94.CrossRefPubMed Bjorkholm M, Askergren J, Holm G, Mellstedt H. Long-term influence of splenectomy on immune functions in patients with Hodgkins disease. Scand J Haematol. 1980;24:87–94.CrossRefPubMed
24.
25.
Zurück zum Zitat Van Den Broek T, Delemarre EM, Janssen WJM, Nievelstein RAJ, Broen JC, Tesselaar K, et al. Neonatal thymectomy reveals differentiation and plasticity within human naive T cells. J Clin Invest. 2016;126:1–11. Van Den Broek T, Delemarre EM, Janssen WJM, Nievelstein RAJ, Broen JC, Tesselaar K, et al. Neonatal thymectomy reveals differentiation and plasticity within human naive T cells. J Clin Invest. 2016;126:1–11.
26.
Zurück zum Zitat Troendle SB, Adix L, Crary SE, Buchanan GR. Laboratory markers of thrombosis risk in children with hereditary spherocytosis. Pediatr Blood Cancer. 2007;49:781–5.CrossRefPubMed Troendle SB, Adix L, Crary SE, Buchanan GR. Laboratory markers of thrombosis risk in children with hereditary spherocytosis. Pediatr Blood Cancer. 2007;49:781–5.CrossRefPubMed
27.
Zurück zum Zitat Das A, Bansal D, Ahluwalia J, Das R, Rohit MK, Attri SV, Trehan AMR. Risk factors for thromboembolism and pulmonary artery hypertension following splenectomy in children with hereditary spherocytosis. Pediatr Blood Cancer. 2014;61:29–33.CrossRefPubMed Das A, Bansal D, Ahluwalia J, Das R, Rohit MK, Attri SV, Trehan AMR. Risk factors for thromboembolism and pulmonary artery hypertension following splenectomy in children with hereditary spherocytosis. Pediatr Blood Cancer. 2014;61:29–33.CrossRefPubMed
28.
Zurück zum Zitat Schilling RF, Gangnon RE, Traver MI. Delayed adverse vascular events after splenectomy in hereditary spherocytosis. J Thromb Haemost. 2008;6:1289–95.CrossRefPubMed Schilling RF, Gangnon RE, Traver MI. Delayed adverse vascular events after splenectomy in hereditary spherocytosis. J Thromb Haemost. 2008;6:1289–95.CrossRefPubMed
30.
Zurück zum Zitat Tsutsumi A, Takahashi R, Sumida T. Mannose binding lectin: genetics and autoimmune disease. Autoimmun Rev. 2005;4:364–72.CrossRefPubMed Tsutsumi A, Takahashi R, Sumida T. Mannose binding lectin: genetics and autoimmune disease. Autoimmun Rev. 2005;4:364–72.CrossRefPubMed
31.
Zurück zum Zitat Pehlivan M, Okan V, Sever T, Balci SO, Yilmaz M, Babacan T. Investiagtion of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura. Platelets. 2011;22:588–95.CrossRefPubMed Pehlivan M, Okan V, Sever T, Balci SO, Yilmaz M, Babacan T. Investiagtion of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura. Platelets. 2011;22:588–95.CrossRefPubMed
32.
Zurück zum Zitat Lammers AJJ, de Porto APNA, Bennink RJ, van Leeuwen EMM, Biemond BJ, Goslings JC, et al. Hyposplenism: comparison of different methods for determining splenic function. Am J Hematol. 2012;87:484–9.CrossRefPubMed Lammers AJJ, de Porto APNA, Bennink RJ, van Leeuwen EMM, Biemond BJ, Goslings JC, et al. Hyposplenism: comparison of different methods for determining splenic function. Am J Hematol. 2012;87:484–9.CrossRefPubMed
33.
Zurück zum Zitat Marques RG, Lucena SBSG, Caetano CER, De Sousa VO, Portela MC, Petroianu A. Blood clearance of Howell-Jolly bodies in an experimental autogenic splenic implant model. Br J Surg. 2014;101:820–7.CrossRefPubMed Marques RG, Lucena SBSG, Caetano CER, De Sousa VO, Portela MC, Petroianu A. Blood clearance of Howell-Jolly bodies in an experimental autogenic splenic implant model. Br J Surg. 2014;101:820–7.CrossRefPubMed
Metadaten
Titel
Persistent changes in circulating white blood cell populations after splenectomy
verfasst von
Minke A. E. Rab
Aafke Meerveld-Eggink
Heleen van Velzen-Blad
Douwe van Loon
Ger T. Rijkers
Okke de Weerdt
Publikationsdatum
26.09.2017
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 2/2018
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-017-2335-9

Weitere Artikel der Ausgabe 2/2018

International Journal of Hematology 2/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.